Position in AZN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$37,690,122
New position
Shares Held
191,107
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $434,660,167 across 16 Drug Manufacturers - General names. AZN ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
243,853 | $85,799,678 | |
| 2 | NVS |
Novartis AG
|
403,774 | $61,676,478 | |
| 3 | LLY |
ELI LILLY & Co
|
60,441 | $55,591,818 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
191,107 | $37,690,122 | |
| 5 | JNJ |
Johnson & Johnson
|
139,822 | $34,178,089 | |
| 6 | MRK |
Merck & Co., Inc.
|
232,295 | $27,942,765 | |
| 7 | GSK |
GSK plc
|
480,636 | $26,526,300 | |
| 8 | SNY |
Sanofi
|
509,464 | $24,545,975 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,690,122 | 191,107 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||